UPC Analytics
ENDE

Decisions

DateCaseDivisionActionMotionOutcomeSummary
2026-01-23UPC_CFI_808/2025Paris LDApplication for provisional measuresPreliminary injunctionPI deniedThe Paris Local Division rejected Guardant Health's application for provisional measures under three patents (EP 3 591 073, EP 3 443 066, EP 3 766 986) against Sophia Genetics. The court found issues of added matter in the divisional patent and insufficient evidence to demonstrate infringement with the required degree of certainty. Guardant Health's request regarding a fourth patent (EP 3 470 533) was withdrawn during proceedings. Guardant Health ordered to pay Sophia Genetics EUR 400,000 as interim costs.
2025-10-22UPC_CFI_587/2025The Hague LDApplication for provisional measuresPreliminary injunctionPI deniedThe Hague Local Division dismissed Abbott Diabetes Care's application for provisional measures against Sinocare and A.Menarini Diagnostics concerning EP 3 988 471, finding that the GlucoMen iCan device does not infringe claim 1 because event data icons are displayed in a separate panel rather than within the timeline graph.
2025-10-17UPC_CFI_624/2025The Hague LDApplication for provisional measuresPreliminary injunctionPI grantedThe Hague Local Division granted Abbott Diabetes Care a preliminary injunction against Sinocare and A.Menarini Diagnostics regarding infringement of continuous glucose monitoring patent EP 4 344 633 (FreeStyle Libre technology), including information orders and delivery-up of infringing GlucoMen iCan products.
2025-10-01UPC_CFI_808/2025Paris LDApplication for provisional measuresProceduralProcedural onlyThe Paris Local Division issued a scheduling order for the oral hearing in Guardant Health's preliminary injunction application against Sophia Genetics entities based on four patents (EP 3 766 986, EP 3 470 533, EP 3 443 066, EP 3 591 073) relating to genomic analysis, after defendants failed to appoint representatives within 15 days of service.